The KENSHE Study

The KENSHE Study
Title:

Single-dose HPV catch-up vaccination efficacy – A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya, KEN SHE Study

Acronym:

KENSHE

Timeline:

2018 – 2027

Status:

Ongoing

Site Principal Investigators:
  • Dr. Nelly Mugo
  • Dr. Ruanne Barnabas
  • Prof. Elizabeth Bukusi
  • Dr. Betty Njoroge
  • Dr. Jared Baeten
  • Rachel Winer
  • Deborah Donnell
  • Elizabeth Brown
  • Connie Celum
  • Denise Galloway
Funder:

Bill and Melinda Gates Foundation

Objective

The major goal of this project is to learn whether a single dose of the HPV vaccine prevents HPV infection among adolescents and young women.

Do you want to be involved in the fight against HPV and Cervical Cancer?

The Kenya Medical Research Institute and University of Washington are conducting a HPV vaccine study among adolescent girls and young women in Nairobi, Thika and Kisumu. This Study is known as the KENSHE Study. Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya The major goal of this project is to learn whether a single dose of the HPV vaccine prevents HPV infection among adolescents and young women

Started in December 2018

1200 participants enrolled from Kisumu County and Environs (1160 are currently on follow-up)